SAGP - ETF AI Analysis
Top Page
Strategas Global Policy Opportunities ETF (SAGP)
Rating:68Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown strong year-to-date and one-month performance, suggesting positive momentum in its strategy.
Global Diversification
Holdings spread across the U.S., Europe, and Asia help reduce the risk of being tied to the economic fortunes of a single country.
Health Care and Industrials Focus
A large tilt toward health care and industrials provides exposure to sectors that can benefit from long-term policy and economic trends.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of your returns go toward fees.
Concentration in a Few Sectors
Heavy weights in health care and industrials mean the fund is less balanced across all sectors and more vulnerable if these areas weaken.
Mixed Performance Among Top Holdings
While several top positions have performed strongly, a few have shown weak or lagging results, which can create uneven returns.
SAGP vs. SPDR S&P 500 ETF (SPY)
AUM77.49M
RegionGlobal
Expense Ratio0.65%
Beta0.72
IssuerStrategas
Inception DateJan 26, 2022
Dividend Yield3.26%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,119
30 Day Avg. Volume3,338
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.61Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering100
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SAGP Summary
The Strategas Global Policy Opportunities ETF (SAGP) is an actively managed fund that looks for companies likely to benefit from changes in government, fiscal, and central bank policies around the world, rather than tracking a set index. It owns a wide mix of stocks across many countries and sectors, with a big focus on health care, industrials, and technology. Well-known holdings include Gilead Sciences and Chipotle. Investors might consider SAGP for global diversification and potential growth tied to major policy shifts. A key risk is that its value can rise or fall quickly as markets react to political and economic news.
How much will it cost me?The Strategas Global Policy Opportunities ETF (SAGP) has an expense ratio of 0.65%, which means you’ll pay $6.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, aiming to adapt to global policy changes for potential growth opportunities.
What would affect this ETF?The SAGP ETF, with its focus on global policy opportunities and diverse sector exposure, could benefit from favorable government policies, increased healthcare spending, and technological advancements, especially given its significant holdings in health care and technology. However, it may face challenges from geopolitical tensions, regulatory changes, or economic slowdowns that could negatively impact sectors like industrials and financials. Investors should also consider how shifts in global monetary policies or interest rates might influence the ETF's performance.
SAGP Top 10 Holdings
SAGP is leaning heavily into health care, with names like Dexcom, Gilead, and Incyte doing much of the heavy lifting as their shares have been steadily rising on solid earnings and drug or device momentum. Industrial exposure via Stanley Black & Decker adds a more cyclical, but currently supportive, tilt as the stock has been climbing after cost-cutting efforts. On the tech side, Palantir is a bright spot with its AI story, while Coinbase has been more of a drag, reflecting choppy sentiment around crypto. Overall, it’s a globally focused, policy-sensitive mix with a clear bias toward medical and innovation-driven plays.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Ciena | 2.15% | $1.66M | $48.29B | 149.38% | 70 Outperform | |
| DaVita | 2.14% | $1.65M | $12.37B | 40.59% | 59 Neutral | |
| Verisign | 2.04% | $1.57M | $26.95B | 5.66% | 62 Neutral | |
| Textron | 2.04% | $1.57M | $13.88B | -3.59% | 75 Outperform | |
| Altria Group | 2.02% | $1.56M | $117.05B | 9.01% | 64 Neutral | |
| Lockheed Martin | 2.02% | $1.56M | $123.99B | 13.61% | 70 Outperform | |
| Teradyne | 2.02% | $1.56M | $53.34B | 197.20% | 71 Outperform | |
| General Dynamics | 1.97% | $1.52M | $97.40B | 9.67% | 80 Outperform | |
| Leidos Holdings | 1.96% | $1.51M | $16.23B | -30.02% | 77 Outperform | |
| Fox | 1.96% | $1.51M | $26.27B | 8.59% | 77 Outperform |
SAGP Technical Analysis
Negative
―
Price Trends
36.86
Negative
35.97
Negative
35.53
Positive
Market Momentum
-0.35
Positive
36.94
Neutral
9.23
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SAGP, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 36.97, equal to the 50-day MA of 36.86, and equal to the 200-day MA of 35.53, indicating a neutral trend. The MACD of -0.35 indicates Positive momentum. The RSI at 36.94 is Neutral, neither overbought nor oversold. The STOCH value of 9.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SAGP.
SAGP Peer Comparison
Comparison Results
Performance Comparison
SAGP
Strategas Global Policy Opportunities ETF
35.91
2.59
7.77%
GOP
Unusual Whales Subversive Republican Trading ETF
―
―
―
MNVT
Moonvest ETF
―
―
―
CAMX
Cambiar Aggressive Value ETF
―
―
―
WCAP
WarCap Unconstrained Equity ETF
―
―
―
TOLL
Tema Monopolies and Oligopolies ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents